Status:
RECRUITING
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Lead Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Collaborating Sponsors:
Società Italiana di Urologia (SIU)
Italian Group for Advanced Laparo-Endoscopic and Robotic Urologic Surgery (AGILE)
Conditions:
Kidney Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Partial nephrectomy (PN) is the standard treatment for localized renal masses and should be preferred in clinical T1 (\<7 cm tumor diameter) renal tumors over radical nephrectomy (RN) whenever technic...
Detailed Description
Study design The overall objective of the i-RECORD project is to build a multicentre multi-arm multi-stage prospective observational registry collecting data on the management of kidney cancer in con...
Eligibility Criteria
Inclusion
- Radiological diagnosis of renal tumor susceptible to active treatment or AS/WW.
- Age ≥18 years
- Informed consent signed
Exclusion
- Patient refuse to participate in clinical research.
- Urothelial renal carcinoma.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05363657
Start Date
January 10 2022
End Date
December 31 2028
Last Update
May 6 2022
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Urology, University of Southern California.
Los Angeles, California, United States, 90007
2
University of California San Diego, Moores Cancer Center
San Diego, California, United States, 92037
3
Stanford University
Stanford, California, United States, 94304
4
Loyola University Medical Center, Edward Hines VA Hospital
Chicago, Illinois, United States, 60141